Alzheimer's Disease: Drug Discovery

• Ētahi atu kaituhi: Huang, Xudong (Editor)
• Hōputu: Tāhiko Wāhanga pukapuka
• Reo: Ingarihi
• I whakaputaina: Australia Exon Publications 2020
• Ngā marau: MJND; Etiology of Alzheimer's Disease; Epidemiology of Alzheimer's Disease; Neuropathology of Alzheimer's Disease; Pathogenesis of Alzheimer's Disease; Immunotherapy for Alzheimer's Disease; Amyloid β-Targeted Inhibitory Peptides for Alzheimer's Disease; Tau Protein-Targeted Therapies in Alzheimer's Disease; Targeting Metal Homeostasis for Alzheimer's Disease; Insulin-Resistant in Alzheimer's Disease; Blood-Brain Barrier in Alzheimer's Disease; Epigenetic Modifications in Alzheimer's Disease; Chimeric Conjugates for Alzheimer's Disease; Multifunctional Ligand Approach for Alzheimer's Disease; Natural Products for Alzheimer's Disease
• Urunga tuihono: DOAB: download the publication; DOAB: description of the publication

Alzheimer's disease is the most common cause of age-related dementia. Alzheimer's disease presents with irreversible cognitive decline, which commences as insidious short-term memory dysfunction and gradually spreads to other cognitive domains, rendering patients mute and non-ambulatory af...